Celyad SA

(CLYYF)

By |

Profile

Celyad SA is a biopharmaceutical company, specialized in cell therapy. It develops technologies and treatments to treat severe diseases with poor prognosis. The company focuses on Immuno oncology, Cardiology, and Medical devices. Its main product candidates include CAR-T NKR-2, C-Cure. The firm has CYAD-01, CYAD-02, CYAD-03 programs in pipeline. The company owns trademarks and service marks including CELYAD, C-CATH, C_CURE, CATH and C-CATHez and CARDIO 3 BIOSCIENCES. The firm has Cardiology and Corporate operating segments. It derives majority of its revenues from Cardiology segment.

Contact Information

Website: www.celyad.com
Email: investors@celyad.com
Main Phone: +32 10394100
Address: Rue Edouard Belin 2
City / Town: Mont-Saint-Guibert
Country: BEL
Postal Code: 1435

Issuer Information

Exchange: GREY
CEO: Christian Homsy
Employees: 77
$ 27.30 $ 0. (0.00%)
Last Price 27.30 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close 27.30
Last Trade Volume 0 52 Wk Hi 38.75 52 Wk Low 27.30
Market Cap 326 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 11,942,344.00 EPS (TTM) -7.39 PE Ratio N/A Exchange Greys